US Patent Issued to Zywie on June 30 for "Modified forms of ambroxol for therapeutic use" (American, Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,567, issued on June 30, was assigned to Zywie LLC (Princeton, N.J.).

"Modified forms of ambroxol for therapeutic use" was invented by Stephen Anderson (Princeton, N.J.), Stephen Pasternak (London, Canada), Vincent Jacques (Somerville, Mass.) and Gerard Joseph Broussard Jr. (Langhorne, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to analog forms of ambroxol and related compounds, compositions comprising same, and methods of preventing and/or treating various diseases and medical conditions involving the administration of analogs of ambroxol and related compounds."

The patent was filed on July 22, 2024, under Application N...